Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo
- PMID: 1277216
Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo
Abstract
The existence of the cyclophosphamide (CP) metabolites, 4-hydroxycyclophosphamide and aldophosphamide, in vivo after application of CP to mice and rats has been demonstrated. The metabolite pattern in the serum and urine of rats at different times after CP application was determined. For this purpose, thin-layer chromatograpic procedure was developed which allows separation of the metabolites without decomposition. Because considerable amounts of radioactivity are bound to serum proteins after 3H-CP application, protein binding studies with CP and CP metabolites were carried out. It was found that 4-hydroxycyclophosphamide is bound to thiol groups of bovine serum albumin yielding a rather stable product which could be isolated by column chromatography on Sephadex.
Similar articles
-
Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.Cancer Treat Rep. 1976 Apr;60(4):403-8. Cancer Treat Rep. 1976. PMID: 1277214
-
Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.Cancer Treat Rep. 1976 Apr;60(4):337-46. Cancer Treat Rep. 1976. PMID: 1277209
-
[Pharmacokinetics of cyclophosphamide and cyclophosphamide metabolites in the mouse and their influence on the therapeutic effect of "activated" cyclophosphamide (4-hydroxycyclophosphamide) (author's transl)].Arzneimittelforschung. 1982;32(6):639-47. Arzneimittelforschung. 1982. PMID: 7202370 German.
-
Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.Arzneimittelforschung. 1982;32(9):995-1012. Arzneimittelforschung. 1982. PMID: 6756419 Review.
-
The chemistry of the metabolites of cyclophosphamide.Curr Pharm Des. 1999 Aug;5(8):627-43. Curr Pharm Des. 1999. PMID: 10469895 Review.
Cited by
-
Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet. 1987 Mar;12(3):168-213. doi: 10.2165/00003088-198712030-00002. Clin Pharmacokinet. 1987. PMID: 3555940 Review.
-
[On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)].Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978 May 31;91(2):127-42. doi: 10.1007/BF00284020. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978. PMID: 27021 German. No abstract available.
-
Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites.Cancer Chemother Pharmacol. 1987;20(3):248-52. doi: 10.1007/BF00570495. Cancer Chemother Pharmacol. 1987. PMID: 3315284
-
Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model.Invest New Drugs. 2010 Dec;28(6):744-53. doi: 10.1007/s10637-009-9308-7. Epub 2009 Aug 27. Invest New Drugs. 2010. PMID: 19711011
-
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.Biochem Pharmacol. 2010 Oct 1;80(7):1063-74. doi: 10.1016/j.bcp.2010.06.002. Epub 2010 Jun 10. Biochem Pharmacol. 2010. PMID: 20541539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous